PPHM

PEREGRINE PHARMACEUTICALS INCCIK 704562 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for PPHM PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for PPHM

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Hancock Richard B	Director	1	$0	$0	2017-11-27
McComb Joel	Director	1	$0	$0	2017-11-27
SARGEN GREGORY	Director	1	$0	$0	2017-11-27
CARLEONE JOSEPH	Director	1	$0	$0	2017-11-27
Shan Joseph	VP, Clinical and Reg Affairs	11	$0	$0	2017-10-31
KING STEVEN W	President & CEO	25	$0	$0	2017-10-31
Bamforth Mark R	Director	9	$225.2K	$0	2017-10-27
Walsh Patrick D	Director	1	$0	$0	2017-10-20
Lias Roger J.	President ***	1	$0	$0	2017-09-25
SWARTZ ERIC S	Director	10	$9.9K	$0	2017-08-25
JOHNSON CARLTON M	Director	9	$0	$0	2017-08-25
POHL DAVID	Director	8	$0	$0	2017-08-25
LYTLE PAUL J	Chief Financial Officer	14	$0	$0	2017-04-28
Fussey Shelley PM	V.P., Intellectual Property	17	$0	$0	2016-10-31
Ziebell Mark R	VP and General Counsel	8	$10.9K	$0	2016-06-02
Masten Jeffrey L.	V.P. Quality	6	$0	$0	2013-05-06

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
CARLEONE JOSEPH	Director	A Award deriv	2017-11-27	2017-11-29	75,000	—	$0	75,000	SEC↗
Hancock Richard B	Director	A Award deriv	2017-11-27	2017-11-29	75,000	—	$0	75,000	SEC↗
McComb Joel	Director	A Award deriv	2017-11-27	2017-11-29	75,000	—	$0	75,000	SEC↗
SARGEN GREGORY	Director	A Award deriv	2017-11-27	2017-11-29	75,000	—	$0	75,000	SEC↗
KING STEVEN W	President & CEO	J Other	2017-10-31	2017-11-01	1,398	$3.87	$5.4K	34,646	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	J Other	2017-10-31	2017-11-01	2,747	$3.87	$10.6K	16,187	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	4,993	$4.49	$22.4K	5,193	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	200	$4.48	$896	200	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	1,800	$4.49	$8.1K	6,993	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	300	$4.49	$1.3K	7,293	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	201	$4.49	$902	7,494	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	5,340	$4.49	$24.0K	12,834	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	35,966	$4.51	$162.2K	48,800	SEC↗
Bamforth Mark R	Director	P Buy	2017-10-27	2017-10-27	1,200	$4.51	$5.4K	50,000	SEC↗
Walsh Patrick D	Director	A Award deriv	2017-10-20	2017-10-24	75,000	—	$0	75,000	SEC↗
Bamforth Mark R	Director	A Award deriv	2017-10-17	2017-10-24	75,000	—	$0	75,000	SEC↗
Lias Roger J.	President ***	A Award deriv	2017-09-25	2017-09-27	150,000	—	$0	150,000	SEC↗
JOHNSON CARLTON M	Director	J Other deriv	2017-08-25	2017-08-29	14,934	—	$0	239,255	SEC↗
JOHNSON CARLTON M	Director	J Other deriv	2017-08-25	2017-08-29	20,024	—	$0	254,189	SEC↗
POHL DAVID	Director	J Other deriv	2017-08-25	2017-08-29	11,908	—	$0	262,305	SEC↗
SWARTZ ERIC S	Director	J Other deriv	2017-08-25	2017-08-29	4,706	—	$0	253,541	SEC↗
SWARTZ ERIC S	Director	J Other deriv	2017-08-25	2017-08-29	15,966	—	$0	258,247	SEC↗
KING STEVEN W	President & CEO	J Other	2017-04-28	2017-04-28	19,941	$0.27	$5.4K	232,730	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2017-04-28	2017-04-28	37,389	$0.27	$10.1K	184,038	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	J Other	2017-04-28	2017-04-28	39,177	$0.27	$10.6K	94,079	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2016-10-31	2016-11-01	25,433	$0.29	$7.4K	135,908	SEC↗
KING STEVEN W	President & CEO	J Other	2016-10-31	2016-11-01	18,826	$0.29	$5.5K	212,789	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2016-10-31	2016-11-01	33,783	$0.29	$9.8K	146,649	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	J Other	2016-10-31	2016-11-01	33,783	$0.29	$9.8K	54,902	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2016-06-02	2016-06-03	150,000	—	$0	893,000	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2016-06-02	2016-06-03	200,000	—	$0	1,919,500	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2016-06-02	2016-06-03	500,000	—	$0	2,976,137	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2016-06-02	2016-06-03	250,000	—	$0	1,547,500	SEC↗
POHL DAVID	Director	A Award deriv	2016-06-02	2016-06-03	200,000	—	$0	1,919,500	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	A Award deriv	2016-06-02	2016-06-03	150,000	—	$0	1,035,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2016-06-02	2016-06-03	200,000	—	$0	1,919,500	SEC↗
Ziebell Mark R	VP and General Counsel	A Award deriv	2016-06-02	2016-06-03	150,000	—	$0	975,000	SEC↗
Ziebell Mark R	V. P., General Counsel	P Buy deriv	2016-05-24	2016-05-24	300	$13.00	$3.9K	900	SEC↗
Ziebell Mark R	V. P., General Counsel	P Buy deriv	2016-05-23	2016-05-24	300	$11.50	$3.5K	300	SEC↗
Ziebell Mark R	V. P., General Counsel	P Buy deriv	2016-05-23	2016-05-24	300	$11.90	$3.6K	600	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2016-04-29	2016-05-02	10,683	$0.30	$3.2K	110,475	SEC↗
KING STEVEN W	President & CEO	J Other	2016-04-29	2016-05-02	10,683	$0.30	$3.2K	193,963	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	J Other	2016-04-29	2016-05-02	10,683	$0.30	$3.2K	21,119	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2015-10-30	2015-11-02	8,448	$0.95	$8.0K	99,792	SEC↗
KING STEVEN W	President & CEO	J Other	2015-10-30	2015-11-02	5,474	$0.95	$5.2K	183,280	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2015-10-30	2015-11-02	6,158	$0.95	$5.9K	112,866	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2015-05-11	2015-05-12	75,000	—	$0	743,000	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2015-05-11	2015-05-12	187,500	—	$0	1,719,500	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2015-05-11	2015-05-12	300,000	—	$0	2,476,137	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2015-05-11	2015-05-12	150,000	—	$0	1,297,500	SEC↗
POHL DAVID	Director	A Award deriv	2015-05-11	2015-05-12	187,500	—	$0	1,719,500	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	A Award deriv	2015-05-11	2015-05-12	100,000	—	$0	885,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2015-05-11	2015-05-12	187,500	—	$0	1,719,500	SEC↗
Ziebell Mark R	V.P., General Counsel	A Award deriv	2015-05-11	2015-05-12	100,000	—	$0	825,000	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2015-04-30	2015-05-01	7,179	$1.11	$8.0K	91,344	SEC↗
KING STEVEN W	President & CEO	J Other	2015-04-30	2015-05-01	4,634	$1.11	$5.1K	177,806	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2015-04-30	2015-05-01	5,217	$1.11	$5.8K	106,708	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2014-10-31	2014-11-04	5,362	$1.36	$7.3K	84,165	SEC↗
KING STEVEN W	President & CEO	J Other	2014-10-31	2014-11-04	3,280	$1.36	$4.5K	173,172	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2014-05-06	2014-05-08	100,000	—	$0	690,500	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2014-05-06	2014-05-08	250,000	—	$0	1,532,000	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2014-05-06	2014-05-08	400,000	—	$0	2,176,137	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2014-05-06	2014-05-08	200,000	—	$0	1,147,500	SEC↗
Shan Joseph	V.P., Clinical and Reg Affai	A Award deriv	2014-05-06	2014-05-08	100,000	—	$0	785,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2014-05-06	2014-05-08	250,000	—	$0	1,532,000	SEC↗
POHL DAVID	Director	A Award deriv	2014-05-06	2014-05-08	250,000	—	$0	1,602,000	SEC↗
Ziebell Mark R	V.P., General Counsel	A Award deriv	2014-05-06	2014-05-08	175,000	—	$0	735,000	SEC↗
KING STEVEN W	President & CEO	J Other	2014-04-30	2014-05-01	4,020	$1.11	$4.5K	169,892	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2014-04-30	2014-05-01	6,571	$1.11	$7.3K	78,803	SEC↗
KING STEVEN W	President & CEO	J Other deriv	2014-04-29	2014-05-01	87,363	—	$0	1,776,137	SEC↗
KING STEVEN W	President & CEO	J Other	2014-04-29	2014-05-01	25,662	—	$0	165,872	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2013-10-31	2013-11-01	6,752	$1.08	$7.3K	72,232	SEC↗
KING STEVEN W	President & CEO	J Other	2013-10-31	2013-11-01	4,131	$1.08	$4.5K	191,534	SEC↗
KING STEVEN W	President & CEO	D To issuer deriv	2013-10-15	2013-10-17	250,000	—	$0	1,683,500	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2013-10-15	2013-10-17	250,000	—	$0	1,933,500	SEC↗
KING STEVEN W	President & CEO	A Award	2013-10-15	2013-10-17	100,000	—	$0	187,403	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2013-05-06	2013-05-08	100,000	—	$0	590,500	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2013-05-06	2013-05-08	250,000	—	$0	1,352,000	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2013-05-06	2013-05-08	400,000	—	$0	1,933,500	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2013-05-06	2013-05-08	200,000	—	$0	1,007,500	SEC↗
Masten Jeffrey L.	V.P. Quality	A Award deriv	2013-05-06	2013-05-08	100,000	—	$0	614,103	SEC↗
POHL DAVID	Director	A Award deriv	2013-05-06	2013-05-08	250,000	—	$0	1,352,000	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	A Award deriv	2013-05-06	2013-05-08	100,000	—	$0	709,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2013-05-06	2013-05-08	250,000	—	$0	1,402,000	SEC↗
Ziebell Mark R	V.P., General Counsel	A Award deriv	2013-05-06	2013-05-08	175,000	—	$0	560,000	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2013-04-30	2013-05-01	10,481	$0.71	$7.4K	65,480	SEC↗
KING STEVEN W	President & CEO	J Other	2013-04-30	2013-05-01	6,516	$0.71	$4.6K	87,403	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2013-04-30	2013-05-01	11,988	$0.71	$8.5K	101,491	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2012-12-27	2012-12-28	150,000	—	$0	490,500	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2012-12-27	2012-12-28	250,000	—	$0	1,102,000	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2012-12-27	2012-12-28	200,000	—	$0	1,573,500	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2012-12-27	2012-12-28	200,000	—	$0	807,500	SEC↗
Masten Jeffrey L.	V.P. Quality	A Award deriv	2012-12-27	2012-12-28	150,000	—	$0	514,103	SEC↗
POHL DAVID	Director	A Award deriv	2012-12-27	2012-12-28	250,000	—	$0	1,102,000	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	A Award deriv	2012-12-27	2012-12-28	150,000	—	$0	609,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2012-12-27	2012-12-28	250,000	—	$0	1,152,000	SEC↗
Ziebell Mark R	V.P., General Counsel	A Award deriv	2012-12-27	2012-12-28	150,000	—	$0	385,000	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2012-10-31	2012-11-01	17,980	$0.39	$7.0K	54,999	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2012-10-31	2012-11-01	20,885	$0.39	$8.1K	89,503	SEC↗
KING STEVEN W	President & CEO	J Other	2012-10-31	2012-11-01	11,000	$0.39	$4.3K	80,887	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2012-05-04	2012-05-08	125,000	—	$0	340,500	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2012-05-04	2012-05-08	250,000	—	$0	852,000	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2012-05-04	2012-05-08	500,000	—	$0	1,373,500	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2012-05-04	2012-05-08	200,000	—	$0	607,500	SEC↗
Masten Jeffrey L.	V.P. Quality	A Award deriv	2012-05-04	2012-05-08	150,000	—	$0	364,103	SEC↗
POHL DAVID	Director	A Award deriv	2012-05-04	2012-05-08	250,000	—	$0	852,000	SEC↗
Shan Joseph	VP, Clinical and Reg Affairs	A Award deriv	2012-05-04	2012-05-08	150,000	—	$0	459,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2012-05-04	2012-05-08	250,000	—	$0	922,000	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	J Other	2012-04-30	2012-05-01	12,498	$0.40	$5.0K	37,019	SEC↗
KING STEVEN W	President & CEO	J Other	2012-04-30	2012-05-01	10,726	$0.40	$4.3K	69,887	SEC↗
LYTLE PAUL J	Chief Financial Officer	J Other	2012-04-30	2012-05-01	12,498	$0.40	$5.0K	68,618	SEC↗
Masten Jeffrey L.	V.P. Quality	J Other	2012-04-30	2012-05-01	12,498	$0.40	$5.0K	12,498	SEC↗
SWARTZ ERIC S	Director	P Buy	2012-03-14	2012-03-15	16,000	$0.62	$9.9K	126,000	SEC↗
SWARTZ ERIC S	Director	A Award deriv	2012-02-17	2012-02-21	90,000	—	$0	672,000	SEC↗
POHL DAVID	Director	A Award deriv	2012-02-17	2012-02-21	90,000	—	$0	602,000	SEC↗
JOHNSON CARLTON M	Director	A Award deriv	2012-02-17	2012-02-21	90,000	—	$0	602,000	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2012-02-17	2012-02-21	82,561	—	$0	606,061	SEC↗
KING STEVEN W	President & CEO	A Award deriv	2012-02-17	2012-02-21	267,439	—	$0	873,500	SEC↗
Fussey Shelley PM	V.P., Intellectual Property	A Award deriv	2012-02-17	2012-02-21	58,000	—	$0	215,500	SEC↗
LYTLE PAUL J	Chief Financial Officer	A Award deriv	2012-02-17	2012-02-21	140,000	—	$0	407,500	SEC↗
Masten Jeffrey L.	V.P. Quality	A Award deriv	2012-02-17	2012-02-21	36,250	—	$0	214,103	SEC↗
Masten Jeffrey L.	V.P. Quality	A Award deriv	2012-02-17	2012-02-21	21,750	—	$0	177,853	SEC↗
Shan Joseph	V.P., Clinical & Reg. Affair	A Award deriv	2012-02-17	2012-02-21	140,000	—	$0	309,000	SEC↗